On March 10, 2022 Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, reported the company will participate and be available for 1×1 meetings at the following upcoming conferences (Press release, Cellectar Biosciences, MAR 10, 2022, View Source [SID1234609880]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Roth Capital Partners 34th Annual Conference
Date: March 15, 2022
Time: 10:00 am PT / 1:00 pm ET
Format: Fireside chat and available for 1×1 investor meetings
Oppenheimer 32nd Annual Healthcare Conference
Date: March 16, 2022
Time: 3:20 pm ET
Format: Virtual presentation and available for 1×1 investor meetings
Webcast: To register, click on the link HERE
A replay of the Oppenheimer presentation will be available on the Investor page of the company website.